Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend.

by Kendall K. Morgan

Advocacy in Action

Two mothers, each with a son who died of brain cancer, worked together to increase awareness and acceptance of tumor tissue donation.

by Esther Landhuis

From the Editor-in-Chief

Increased vaccination rates can help reduce cervical cancer as a worldwide health threat.

by William G. Nelson, MD, PhD

For a small group of pancreatic cancer patients who were able to receive therapies targeting the molecular alterations in their tumors, these matched therapies were associated with longer life.

by Cheryl Platzman Weinstock

Cancer patients and their families share stories of fear, love and uncertainty as they find new ways to support each other.

by Jen Tota McGivney

Responding to the coronavirus, patient advocates and nonprofits expand existing outreach initiatives and launch new ones.

by Marci A. Landsmann

Researchers are working to expand the benefits of immunotherapy by making “cold” tumors “hot” so they can respond better to treatments.

by Kendall K. Morgan

Patients find each other online and get support they say is unparalleled, but with openness comes concern about privacy.

by Kate Yandell

A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data.

by Marci A. Landsmann

Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.

by Sue Rochman